Zhejiang Hisoar Pharmaceutical Co Ltd

chinadaily.com.cn | Updated: 2019-02-19

Print Print


Zhejiang Hisoar Pharmaceutical Co Ltd [Photo/hisoar.com]

Zhejiang Hisoar Pharmaceutical Co Ltd, located in Taizhou, Zhejiang province, is a listed company producing special active pharmaceutical ingredients (APIs), formulations and fine chemicals, dyes and dye intermediates.

Hisoar Pharmaceutical is one of the top 100 innovative enterprises in China's pharmaceutical industry, a key high-tech enterprise of the China Torch Program, among the first Zhejiang provincial integrity model enterprises and a Zhejiang provincial excellent self-supporting export and production enterprise.

The company has several holding subsidiaries such as Zhejiang Hisoar Chuannan Pharmaceutical Co Ltd, Zhejiang Hisoar Sales Pharmaceutical Co Ltd, Shanghai Hisoar Medical Technology Co Ltd, Taizhou Qianjin Chemical Co Ltd, Taizhou Quanfeng Pharmaceutical Chemical Co Ltd and Genevida GmbH Co Ltd.

The main products of the company are APIs such as antibiotics, cardiovascular drugs, antidiabetic drugs and fine chemicals, preparations, dyes and intermediates. More than 70 percent of the pharmaceutical products are exported, and the production of the clindamycin series of drugs is in the top position in the world.

The company attaches great importance to building EHS (environment, health and safety) and GMP (Good Manufacturing Practices) systems, and has dozens of products registered with the US Food and Drug Administration (FDA). It has obtained a European Union CEP (COS) certificate (Certificate of Suitability to the Monographs of the European Pharmacopoeia), and has passed both Japanese and Chinese GMP certification. Its dye products are exported to more than 30 countries and regions. The reactive dye ranbapai is rated as a China top brand and national excellent torch program product.

Address: No 100 Waisha Branch Road, Jiaojiang district, Taizhou, Zhejiang province

Post code: 318000

Tel: +86-576-89088166

Fax: +86-576-89088128